Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. joins the UN Global Compact, the world’s largest corporate sustainability initiative. Corporate NewsBy adminJune 20, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. commences the production of antiviral COVID-19 treatment, Molnupiravir Rameda Corporate NewsBy adminJune 17, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a fast-growing anticonvulsant which grew at 2019-21 CAGR of 226% Corporate NewsBy adminJune 15, 2022
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires fast-growing molecule with an established market presence Corporate NewsBy adminMay 23, 2022
Equinox Pharma Holding Limited (Equinox), alongside other investors, further increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Corporate NewsBy adminMarch 7, 2022
